SightfileU.S. market data from official filings

LENZ THERAPEUTICS INC (LENZ)

Name: LENZ THERAPEUTICS INC (LENZ) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001815776 · EDGAR filings · Updated 2026-07-02

LENZ THERAPEUTICS INC (LENZ) has reported institutional ownership of 105.7%, with 144 institutional managers holding positions valued at $303.3M per the latest 13F reporting period.

Institutional ownership

105.7%

Institutional managers

144

Reported 13F value

$303.3M

Insider activity

44 trans.

−$66.2M net selling

Latest updates

2026-07-02 — Current report (8-K) filed
2026-06-26 — SCHEDULE 13G filed
2026-06-15 — Insider transaction reported (Form 4)
2026-06-15 — Insider transaction reported (Form 4)
2026-06-15 — Insider transaction reported (Form 4)
2026-06-15 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, LENZ THERAPEUTICS INC has 144 institutional holders and institutional ownership of 105.7%.

Insider activity

Insiders reported 44 transactions (6 buys, 36 sells) across 10 reporting insiders, with a net reported value of −$66.2M.

Related companies

ADC THERAPEUTICS SA (ADCT) · CENTURY THERAPEUTICS INC (IPSC) · LUMEXA IMAGING HOLDINGS INC (LMRI) · KYVERNA THERAPEUTICS INC (KYTX) · AQUESTIVE THERAPEUTICS INC (AQST) · INVIVYD INC (IVVD)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.